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 Abstract 
Within the past few decades, lactate research has expanded from initial 
findings deeming lactate as a dead-end metabolic product to recognition of 
lactate’s role as a potential energy substrate in the CNS. Due to the tight 
relationship between lactate and energy metabolism, interest in the scientific 
community has been mounting around associations among metabolic 
dysregulation, elevated lactate and neurodegenerative states such as 
Alzheimer’s, Parkinson’s, amyotrophic lateral sclerosis, ischemia/reperfusion 
(AD, PD, ALS, I/R injuries), and physiological aging, however underlying cellular 
mechanisms and/or facilitators for neuronal degeneration pathologies still remain 
unknown. Here, we tested several hypotheses that implicate L-lactate to various 
neurodegenerative mechanisms: increases in cytosolic calcium, increases in 
cytosolic reactive oxygen species (ROS), increases in intracellular acidification, 
and subsequently, increases in cellular death in primary neuronal cultures and 
dopaminergic-like NGF-derived PC12 cells. Treatment of cells with a pathologic 
concentration of L-lactate (4 mM) induced significant increases in cytosolic 
calcium, cytosolic ROS, and intracellular acidification measured in real time with 
fluorescent markers and quantified using ImageJ software. Furthermore, 
treatment with L-lactate (4 mM) induced significant increases in cell death, 
measured in real time and using flow cytometry in support. We conclude that L-
lactate increases cellular events commonly observed in cells undergoing 
xiii 
degeneration, providing support for the implications of lactate in 
neurodegenerative disorders.  
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 Literature Review 
1.1 Introduction 
 
Despite hundreds of years of study, the mechanisms behind the complex 
network of physiological processes that constitute pathological human conditions 
remain under investigation. At the molecular level, cells have the ability to 
communicate and adapt to changes in the internal environment of the body, 
which provide a dynamic means of survival and allows for continual function. 
However, when cells are exposed to continuous stressors and/or fail to 
effectively adapt, injury and apoptosis or necrosis ensue. Maintaining cellular 
homeostasis is crucial to the proper functioning of the various bodily systems in 
concert with one another. The nervous system provides the necessary machinery 
for communication within the body, sensory perception of the world around us, 
motor function to allow us to traverse the external environment, and autonomic 
function to control organ and endocrine systems within us. The brain and spinal 
cord of the central nervous system (CNS) communicate via cranial and spinal 
nerves with the peripheral nervous system (PNS). Proper neuron function is 
extremely important to human survival, so there are specialized adaptive 
measures in the body to protect the nervous system. Neuroglial cells, such as 
oligodendrocytes, microglia, and astrocytes, function to metabolically support and 
provide a means of protection for neuron cells. The brain is separated from the 
rest of the body by the blood brain barrier (BBB) and the cerebrospinal fluid 
(CSF)-brain barrier, which create a filtered environment for neurons specialized 
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to pH, ion, and energy substrate preferences. The BBB consists of endothelial 
cells connected with tight junctions, basement membrane, and astrocytes. 
Oxygen, carbon dioxide, and water can freely pass through the BBB, however 
larger and chemically charged molecules require regulated transport, allowing for 
further protection of the CNS. 
Energy homeostasis within the brain is closely regulated and a laboring  
physiological task, as it accounts for nearly 20% consumption of total resting 
cardiac output and oxygen (14) . The importance of homeostasis within the CNS 
cannot be understated, as minutes without blood and/or oxygen supply can have 
permanent damaging effects (63). Under ischemic conditions, the lack of blood 
flowing to and from the brain can lead to the build-up of toxic by-products of 
metabolism, increasing the rate of neuronal damage. One of the major energy 
substrates used by the brain is glucose, however for this the neurons rely on 
blood glucose or glycogen supplied from neuroglia. Recent studies have shown 
that the brain can aerobically utilize lactate as an energy substrate via the krebs 
cycle (26), and have also implicated the importance of lactate as an oxidative 
energy substrate (8, 14, 56, 73).  
Disruption of cellular and energy homeostasis is the hallmark of various 
neurodegenerative disorders and injury to the brain. Characterized by the 
deterioration of neuronal circuits, homeostasis dysregulation impairs cell-to-cell 
communication critical for healthy bodily function (10). Neuronal degeneration 
also occurs in the normal aging process, leading to cognition and memory 
impairment. Through extensive  cellular and molecular research, common 
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mechanisms underlying neurodegenerative pathologies have been identified, 
however precise etiology behind these conditions still remains largely unsolved.  
1.2  Neurodegenerative Diseases 
 
Traumatic brain injury, aging, and degenerative changes to neurons can 
affect the ability to effectively process information and can damage cognitive 
function. A hallmark of many neurodegenerative disorders is cognitive 
impairment, which reduces the ability to perceive sensory input, process 
information, form new memories and recollect old ones. Although 
neuropathological diseases encompass varying symptoms or injuries, there are 
similar underlying mechanisms associated with neurodegeneration such as 
oxidative stress (5, 23, 47, 57, 65),  excitotoxicity (10, 15, 19, 20, 44, 62), 
dysfunction of mitochondria (16, 28, 31, 32, 39, 43, 66, 68), protein aggregation 
(23, 47), and alterations in gene expression (15, 47). Regardless of the 
processes, it is likely to be a combination of genetic predispositions and 
environmental factors that contribute to the extent and severity of these 
digressions.   
Aging is an inevitable process of life that encompasses similar physiological 
changes that occur in pathologic neurodegeneration. A 2016 population study 
demonstrated that autopsies from brains of aged people lacking a 
neurodegenerative disease diagnosis still presented with amyloid-β (Aβ), 
neurofibrillary tau protein tangles, Lewy bodies, neuronal loss, and reduction in 
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brain volume (22, 69). It still remains under investigation as to whether these 
features are antecedents of neurodegenerative disease or artifacts of aging. 
Advances in modern medicine have resulted in growth among the population of 
people aged 60 and older, with numbers anticipated to increase to account for 
28% of the total population in North America and 35% in Europe by 2050 (United 
Nations, 2017). With such a strong similarity between aging and 
neurodegeneration, precise cellular mechanisms need to be further elucidated. 
In ischemic brain conditions, there is a halt in glucose delivery within minutes, 
and under anaerobic conditions this can lead to increased lactate production and 
exhaustion of ATP. The majority of energy use by nervous tissue is used in 
maintaining ionic concentration gradients (such as the Na+/K+-ATPase pump), 
which can account for fluctuations in ions such as sodium, calcium, and 
potassium that are instrumental to neuronal communication and function. If the 
ischemic episode is not controlled, total brain death ensues. Even if the ischemic 
tissue is reperfused, this has been documented to contribute to secondary brain 
injury via inflammation and noxious by-products, which can compound the 
injuries received from ischemia (Figure 1-1). Of note are the role reactive oxygen 
(ROS) and nitrogen species (RNS) have in ischemia reperfusion injuries, 
regulating apoptosis (59, 63). Under anaerobic conditions, cellular stores of ATP 
are rapidly depleted, requiring cells to produce energy via the less-effective 
anaerobic respiration. This anaerobic environment impairs the ability of the citric 
acid (TCA) cycle to re-oxidize NAD+ to NADH, can lead to accumulation in the 
build-up of lactate, damage mitochondria and their ability to scavenge free 
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radicals, increase levels of intracellular ROS and RNS, and exacerbate cell 
death. The use of antioxidants as treatment to mitigate the free radical insult is 
being explored (9, 30, 50, 65). 
 
Figure 1-1. Proposed Sequence of Events Occurring During 
Ischemia/Reperfusion Injuries. 
 
The cells that require the highest energy usage, neurons and myocytes, have 
been the focus around the degenerative processes that encompass Parkinson’s 
disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), 
multiple sclerosis (MS), and aging in general (23, 27, 69). A growing body of 
evidence points towards the dysfunction of mitochondria as an underlying cause 
of many neurodegenerative diseases such as PD (7, 27, 43), AD (5, 13, 16, 20), 
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and ALS (27, 43, 44, 60, 72). The mitochondria are key players in energy 
metabolism and largely function to produce ATP. Through the glycolytic pathway, 
glucose is converted to pyruvic acid in the cytosol, which then enters the 
mitochondria. Once inside, pyruvate is quickly converted to acetyl coenzyme A 
(coA), which enters the tricarboxylic acid (TCA) cycle. Glycolysis and the TCA 
cycle only account for a net gain of 4 ATP from the original glucose molecule. 
Most of the ATP used to supply cellular functions arise from the last stage of 
cellular respiration: the oxygen-dependent electron transport chain, which results 
in a net gain of 34 ATP. Since most of the energy generated in mitochondria 
depends on the presence of oxygen to facilitate this process, cells cannot survive 
efficiently for prolonged periods without fresh oxygen supply. It has been 
documented that electrons can escape from the electron transport chain, and this 
can be exacerbated during mitochondrial dysfunction, leading to the production 
of superoxide anions, generating ROS (39). As a means of regulating ROS 
formation via scavenging, mitochondria are equipped with antioxidant systems. 
Only when the formation of ROS exceeds the formation of antioxidants, will the 
cell undergo oxidative stress. This can occur due to abnormally high production 
of ROS and/or dysfunction in free radical scavenging capabilities. ROS can 
stimulate the uptake of glucose into the mitochondria, further generating more 
ROS (39). Increased levels of cytosolic ROS are implicated in many pathological 
states, especially AD and PD (59).  
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1.3 Glutamate Excitotoxicity 
 
In many neurological disorders, neuronal damage can be facilitated through a 
host of mediators such as excitatory neurotransmitters, free radicals, nitric oxide 
(NO), inflammatory cells, and apoptotic responses. Excitotoxic injury to the brain 
occurs as a result of excessive activity of excitatory neurotransmitters and their 
interactions with respective receptors, and can be acute (stroke, ischemia, 
trauma) or chronic (as seen in neurodegenerative disorders) in nature. The 
primary excitatory neurotransmitter in the brain is glutamate, which facilitates 
numerous high-order functions such as memory, cognition, motor function, and 
sensory experiences. The action of glutamate occurs at glutamate family 
receptor ion channels, such as the α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid receptor (AMPA-R) and the N-methyl-D-aspartate 
receptor (NMDA-R). Of particular interest in studies of neurodegeneration are 
ligand-gated calcium channels, which facilitate entrance of calcium into the 
intracellular space, leading to increased firing and duration of action potentials 
fired by neurons. Primary literature suggests calcium channel-driven implications 
in CNS injury, as excessive influx of calcium into the intracellular space can 
initiate a calcium-cascade of events that include acidification of the cell and the 
release of enzymes that propagate cellular destruction (19, 48, 59, 71) (Figure 1-
2).   
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Figure 1-2. Calcium-Induced Apoptotic Pathway via Calcium Channel Activation. 
 
Acute glutamate excitotoxicity can be remedied through the removal of 
excess glutamate or by blocking its downstream effects. One of the cornerstones 
of AD diagnosis is the presence of Aβ plaques or oligomers (38, 45, 61). 
Mounting evidence points to the role of Aβ oligomers in disrupting glutamate 
neurotransmission (19, 20), and Aβ has been shown to induce NMDA-R calcium 
currents, oxidative stress, and apoptosis in primary cortex and hippocampal 
cultures (19, 48, 51). The clinical significance of calcium channels in 
neurodegeneration is supported through the Food and Drug Administration 
(FDA), with their approval of Memantine, a non-competitive NMDA-R pore 
blocker, as the current treatment strategy in reducing neuronal loss associated 
with AD (19, 20, 25, 61).  
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1.4 Lactate 
 
Most of the research conducted in the 1900’s was evaluating the role of lactic 
acid/lactate as a by-product of energy metabolism that occurs in exercising 
muscle (33, 36, 37). While this holds true, further advances in cellular and 
molecular techniques are opening up avenues of further investigation of lactate 
as a potentially significant energy substrate for the CNS. 
Lactate (and its conjugate acid, lactic acid) has a similar chemical structure to 
glutamate, which may mimick the carboxyl terminals located on each end of 
glutamate (Figure 1-3). It is through this feature that lactate can partially agonize 
glutamate sites at glutamatergic ion channel receptors such as NMDA-R. 
 
Figure 1-3. Pertinent Chemical Structures. 
Chemical structures of A) glutamate, B) lactic acid, and C) lactate. 
 
One of the most significant physiologic roles of lactate is in regards to the 
Cori cycle. Also known as the lactic acid cycle, it is the process by which lactate 
provides an energy substrate for muscles during the anaerobic conditions of 
exercise. Under normoxic conditions, the ATP needed for muscular activity is 
supplied via pyruvate conversion through the TCA cycle and especially through 
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subsequent oxidative phosphorylation. Under hypoxic conditions, as occurs in 
chronically working skeletal muscles, ATP supply is dependent on the less 
sufficient anaerobic metabolism. Instead of entering the TCA cycle, pyruvate is 
converted to lactate by the enzyme lactate dehydrogenase (LDH), which oxidizes 
NADH to NAD+ in order to reduce pyruvate into lactate (Figure 1-4).  
 
 
Figure 1-4. Monocarboxylate Transporter (MCT) Dysregulation. 
Lactate is utilized in the mitochondria to convert to pyruvate and fuel the 
tricarboxylate acid cycle (TCA). When there is cellular dysfunction, either 
producing excess lactate that overwhelms the system, or through dysfunction in 
MCTs, the TCA cycle does not take place, creating a feed forward mechanism 
whereby lactate accumulates in the tissue. 
 
As a means of reducing lactic acidosis experienced in muscles in an 
anaerobic environment, gluconeogenesis occurs in the liver. Through this 
11 
process, lactate is converted back into pyruvate via LDH, with pyruvate then 
converted back to glucose. This glucose travels from the liver to the muscles 
through the bloodstream, where the cycle repeats itself. Gluconeogenesis is a 
costly process, in terms of ATP consumed, so the Cori cycle cannot be sustained 
chronically without overwhelming the cellular systems (Figure 1-5). If lactic 
acidosis is sustained, this can lead to increased intracellular calcium, protein 
misfolding, excitotoxicty, and subsequent cell death.  
 
Figure 1-5. The Cori Cycle.  
In exercising muscle, glucose is transported into muscle tissue by glucose 
transporter (GLUT), where glycolysis then takes place, converting one glucose 
molecule into two pyruvate molecules and generating a net gain of 2 ATP. 
Lactate dehydrogenase (LDH) converts the two molecules of pyruvate into two 
molecules of lactate, oxidizing NADH to utilize the electrons. Lactate is 
transported out of muscle, into the bloodstream, and into liver cells through the 
monocarboxylate transporter (MCT). In the liver, gluconeogenesis takes place, 
converting lactate back into glucose, at the expense of 6 ATP. 
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Lactate transfer across cell membranes is facilitated by transmembrane 
proteins called monocarboxylate transporters (MCTs). As their name suggests, 
these co-transporters allow for bi-directional movement of monocarboxylates 
(such as lactate and pyruvate) and protons across cellular membranes in a 
concentration and pH-dependent manner (34). These transporters allow for the 
flow of lactate from astrocytes to neurons to be used as an energy substrate in 
anaerobic conditions (8, 49, 53, 64, 70), and also intracellular expression for 
movement of lactate in and out of mitochondria (29, 34, 60). Dysregulation of 
MCT’s are implicated in rises in lactate concentrations and subsequent acidosis 
and if prolonged, cell death (53).  
Recent literature is pointing towards the significance of lactate as an energy 
substrate. The biochemical make-up of blood, extracellular fluid, and CSF are 
varying, with specific regulatory measures for maintaining proper homeostasis. 
These different fluids have varying content of energy substrates: it has been 
reported via microdialysis data collected from humans and rats that baseline 
glucose and lactate concentration in the extracellular fluid of the cortex and 
hippocampus is about 1-2 mM and 2-5 mM (respectively), with blood glucose and 
lactate concentrations reaching about 5-7 mM and 1-2 mM (respectively) (1). 
Another study with a rat model showed that in vivo, a shift in energy substrate 
concentrations occurred in extracellular fluid upon electrical stimulation. 
Increased neuronal activity induced a decrease in glucose concentration and a 
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significant increase in lactate concentrations (36). Taken together, these findings 
point towards the potential of lactate as a preferred energy source for neurons.  
Interestingly, in majority of persons diagnosed with ALS, a neurodegenerative 
disease characterized by gradual loss of motor neurons and subsequent 
muscular atrophy, the muscular function of the eyes remain working. It has been 
shown that ocular muscles and nerves use lactate as an energy substrate, thus 
these tissues do not fatigue when exposed to lactic acid as is seen in skeletal 
musculature (4). Furthermore, it has been reported that LDH activity is detected 
in eye muscles (37) and oculomotor neurons (33). Taken together, these findings 
suggest that the eye muscles and associated neurons possess the cellular 
machinery to withstand abnormally high amounts of lactate without subsequent 
cellular degeneration. The existence of an ATP-dependent muscular-neuronal 
lactate shuttle (MNLS) has been proposed as a means of sustaining lactate 
homeostasis among motor neurons and muscles (44). Dysfunction among LDH, 
mitochondria and/or the MNLS are all proposed mechanisms by which lactate 
can accumulate at the neuromuscular junction (NMJ) and contribute to the 
toxicity factor in the pathogenesis of ALS. 
1.5 Cerebrospinal Fluid Abnormalities 
 
Cerebrospinal fluid (CSF) lactate concentrations are used as an analytical 
tool in diagnosing nervous system infections, such as bacterial and aseptic 
meningitis (54). Alteration in lactate CSF levels has been gaining momentum in 
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the research world as an indicator of many neurodegenerative diseases. A 2016 
study reported elevated concentrations of CSF lactate in relapsing-remitting 
multiple sclerosis (MS) patients (n=118) that increased with increased disease 
progression, indicated by factors such as progression index (PI), MS severity 
scale (MSSS), and Beyesian risk estimate for MS (BREMS) (2). Also indicated in 
this study was a positive and significant correlation between CSF lactate and 
CSF concentrations of tau and neurofilament proteins, well-accepted markers for 
neurodegenerative disorders. A recent study of patients who were diagnosed 
with a variety of neurodegenerative diseases such as ALS, PD, and Huntington’s 
disease, demonstrated an increase in CSF lactate levels of neurodegenerative 
patients aged 65 years and older compared to their younger counterparts, and a 
positive correlation between CSF lactate and glucose levels. 
An elevation of lactate in the CSF (typically considered > 2.1 mM) can be a 
crucial indicator of mitochondrial dysfunction, which is implicated in 
neurodegenerative disease progressions as mentioned. It has been shown 
however, that patients with mitochondrial disease may have normal CSF lactate 
concentrations except when enduring cellular stress, as experienced in 
metabolically demanding tasks such as strenuous exercise (32). If a disease 
presents with mitochondrial dysfunction, this would facilitate an environment of 
increased metabolic stress, thus increasing the levels of lactate that accumulate 
in the CSF.  
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1.6 Hypothesis 
 
Major findings in cellular mechanistic neurodegenerative studies include: 
increased ROS, glutamate excitotoxicity, increased cytosolic calcium, and cell 
and body acid/base issues (Figure 1-6). 
 
Figure 1-6. Lactate Accumulation Contribution to Cytotoxicity. 
 
We hypothesized that since a majority of neurodegenerative diseases 
present with elevated lactate concentrations, the lactate may serve as an 
exictatory feed forward mechanism propagating not only cell death, but also 
contributing to β-amyloid and cognitive decline. Therefore, in this study we 
explored the effects of lactate on apoptosis, cytsolic reactive oxygen species, 
intracellular calcium concentrations, and cytosolic pH in dopaminergic-like PC12 
cells. 
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 Elevated L-lactate Drives Major Cellular Pathologies 
Associated with Neurodegeneration 
2.1 Abstract 
Within the past few decades, lactate research has expanded from initial findings 
deeming lactate as a dead-end metabolic product to recognition of lactate’s role 
as a potential energy substrate in the CNS. Due to the tight relationship between 
lactate and energy metabolism, interest in the scientific community has been 
mounting around associations among metabolic dysregulation, elevated lactate 
and neurodegenerative states such as AD, PD, ALS, I/R injuries, and 
physiological aging, however underlying cellular mechanisms and/or facilitators 
for neuronal degeneration pathologies still remain unknown. Here, we tested 
several hypotheses that implicate L-lactate to various neurodegenerative 
mechanisms: increases in cytosolic calcium, increases in cytosolic reactive 
oxygen species (ROS), increases in intracellular acidification, and subsequently, 
increases in cellular death in primary neuronal cultures and dopaminergic-like 
NGF-derived PC12 cells. Treatment of cells with a pathologic concentration of L-
lactate (4 mM) induced significant increases in cytosolic calcium, cytosolic ROS, 
and intracellular acidification measured in real time with fluorescent markers and 
quantified using ImageJ software. Furthermore, treatment with L-lactate (4 mM) 
induced significant increases in cell death, measured in real time and using flow 
cytometry in support. We conclude that L-lactate increases cellular events 
commonly observed in cells undergoing degeneration, providing support for the 
implications of lactate in neurodegenerative disorders.  
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2.2 Introduction 
 
Cell homeostasis is critical to healthy bodily functions, and fluctuations in 
the cell environment lead to the activation of various compensatory mechanisms 
to ensure appropriate function. Proper homeostatic function is especially critical 
in the central nervous system (CNS), as pathological changes in intracellular and 
extracellular environment of neurons are observed in patient’s experiencing 
neurodegeneration, both in disease models and as a result of normal aging (11, 
15, 49, 69).  
. A key player in energy homeostasis within cell bodies, including neurons, 
are the mitochondria. Active mitochondria generate ATP and NAD+ for cells, and 
in neurons this provides energy to keep pre- and post-synaptic sites functioning 
properly (70, 73). The early symptoms of dementia such as confusion and 
memory loss have been linked to synaptic dysfunction due to build up of β-
amyloid oligomers characteristic of AD (20) and increased oxidative stress in 
mitochondria (47, 65, 66). Age has also been identified as one of the greatest 
risk factors for development of dementia (69), however additional factors such as 
glutamate excitotoxicity (8, 44, 45, 62), intracellular calcium-induced cascades 
(30, 63), oxidative stress (23, 57), and inflammatory factors (35, 47) can also 
increase the risk of developing neuronal loss characterized in degenerative 
diseases, such as Alzheimer’s disease (AD), Parkinson’s disease (PD), 
amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), and normal human 
aging. Mitochondrial dysfunction can lead to reduced energy/ATP generation 
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(11), impaired free radical scavenging capabilities (52) and dysfunctional 
monocarboxylate transporters (29, 34, 70). It is through these impaired cellular 
processes that ROS accumulates in cell bodies such as neurons, eventually 
triggering an apoptotic-cascade ending in neuronal death. The Alzheimer’s 
Association estimates that 5.5 million Americans live with AD (2017), with 
majority of AD patients at least 65 years of age or older. Due to advances in 
medicine and subsequent prolonged life expectancy, the prevalence of 
neurodegenerative disorders is predicted to dramatically increase, pressing a 
huge demand on the scientific and medical community for better understanding 
of neurodegeneration to employ more effective treatments. 
For most of the 19th and 20th centuries, lactate was only regarded as a 
dead-end product in exercising muscles after metabolism, but current research is 
reconsidering the role and significance of lactate as: (1) a fuel source to meet the 
energetic requirements of neurons (4, 8, 14, 26, 29, 44, 53, 56, 64, 70, 73) and 
(2) a necessary signaling molecule for neuronal plasticity (71). Furthermore, 
research has been conducted in primary culture mouse neurons and in vivo 
showing that L-lactate can function as a signaling molecule that stimulates 
plasiticity-related gene expression in neurons (71), in addition to functioning as 
an energy substrate for neurons. On a molecular basis, L-lactate functions as a 
mediator for long-term plasticity and memory through the induction of expression 
of immediate early genes (IEGs), such as early growth response 1 (Egr1), c-Fos, 
and Arc. This is achieved via action at N-methyl-D-aspartate receptors (NMDA-
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R), as MK801, an NMDA-R antagonist, completely abolished L-lactate-induced 
Arc and Egr1 expression (71). 
There is a growing basis of research indicating that accumulation of 
lactate in the central nervous system, through impairment of MCTs (29, 34, 70), 
altered activity of lactate dehydrogenase (LDH), and/or hypoxic/ischemic 
conditions (63), can lead to metabolic acidosis, increased ROS, and increased 
levels of intracellular calcium. In anaerobic conditions, as occurs in hypoxia or 
ischemia, mitochondrial oxidative phosphorylation is impaired, leading to an 
increased production of lactate and if prolonged, deleterious cellular responses 
such as cytosolic acidosis (42). Protein structure and function is largely regulated 
by chaperone molecules, such as GRP78 and CHOP, and lactic acidosis can 
contribute to conformational changes to these molecules, reducing their activity 
and further exacerbating the acidosis. Blood lactate concentrations are usually 1-
2 mM at rest, however with excess accumulation as experienced during intense 
exercise, these levels can exceed 20 mM (12). Blood or CSF lactate increases 
(>2.1 mM) (32) can be an indicator of mitochondrial disease, however this 
dysfunction can go undetected in patients due to normal pyruvate and lactate 
levels except when the individual is exercising or has been subjected to adverse 
metabolic conditions (such as seen in ischemic injuries and neurodegenerative 
states). Rises in CSF lactate have been well established in neurodegenerative 
disease models (2, 3, 44, 49, 62, 71, 72). 
In this study we attempt to eluicidate more precise cellular mechanisms 
associated with the cognitive and memory decline surrounding 
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neurodegeneration. As the CNS functions primarily though the use of 
neurotransmitters, such as the excitatory transmitter glutamate, disregulation or 
aberrant expression of neurotransmitters has been well established in CNS 
pathologies. The excitotoxic result of excessive glutamate binding occurs through 
increased calcium influx into the cell, triggering a cascade of neurotoxic cellular 
events, such as neuronal depolarization and binding with calmodulin to lead to 
increased nitric oxide (NO) formation. This can further exacerbate 
neurodegeneration. Based on mounting evidence, we posit that lactate is a key 
player in many of the pathological states that occur during the development and 
progression of neurodegeneration. Elevated levels of cerebral spinal fluid (CSF) 
lactate, chronically, can lead to cytotoxic insult and ensuing cell death (as 
observed in strokes, ischemia reperfusion injuries, and neurodegeneration). 
Therefore, we hypothesized that administration of lactate to primary neuronal 
cultures and dopaminergic-like NGF-derived PC12 cells would elicit increases in 
cell death, intracellular calcium, intracellular reactive oxygen species (ROS), and 
cytosolic acidification; all hallmark aspects of neurodegeration processes (Figure 
2-1). 
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Figure 2-1. Hypothesis Model for Lactate-induced Cell Death.  
Lactate binds with calcium channel receptors that induce an influx of calcium into 
the cell body. Intracellular calcium elicits increases in neuronal excitability and 
decreases in cytosolic pH that can directly contribute to cell death. Cytosolic 
calcium also increases reactive oxygen species (ROS) formation, creating a 
positive-feedback loop, inducing oxidative stress in the mitochondria, leading to 
increased production of lactate, decreases in pH, and further increases 
intracellular calcium. Oxidative stress is often followed by ER stress in 
dysfunctional cellular environments, further increasing cytosolic ROS. If ER 
stress is prolonged, protein aggregates begin accumulating, eliciting the unfolded 
protein response (UPR). Activation of the UPR leads to increased mRNA 
expression of GRP78, and the accumulation of protein aggregates can contribute 
to G2 cell cycle arrest. DNA damage due to oxidative stress is another 
contributor to G2 cell arrest. Taken together, these mechanisms can further 
exacerbate cell death. 
2.3 Methods 
2.3.1 NGF-Derived PC12 Cell Culture 
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PC12 cells (American Type Culture Collection, USA) were prepared by 
placing cells in a 37.9 °C media cocktail containing: 50 mL of Dulbecco’s 
Modified Eagle Medium (DMEM), 10% horse serum (HS), 5% fetal bovine serum 
(FBS), 1% penicillin, and nerve growth factor (NGF) at 20 ng/mL. Cells were 
plated according to the experiment to be run (24 well plates; ThermoFisher) and 
placed in a 37.5 °C humidified CO2 (5%) incubator. Cells were grown to 75-80% 
confluency and not passaged more than 10 times before new cells were used. 
2.3.2 Preparation of Neuronal Cultures 
 
Whole brain neuronal cultures were made from 1 day old SD rats 
according to our previous publication (58). Briefly, rats were anesthetized with 
pentobarbital (50 mg/kg) and the brains extracted, dissected, combined, brain 
cells dissociated and cells plated on poly-L-lysine pre-coated culture dishes. Two 
days following plating, cultures were treated for two days with cytosine 
arabanoside (ARC, 10μM) to kill off rapidly dividing cells (astroglial and 
astrocytes) followed by fresh ARC free media for the remainder of cultures. 
Neuronal cultures contained > 90% neurons with the remainder primarily 
astroglial. Neuronal cell cultures were grown for 10-14 days before use in cell 
culture experiments.   
2.3.3 Cell Treatment 
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Before application of treatments, cells were observed for healthy neurite 
outgrowth. Once cells were deemed viable, the previous cell media was 
aspirated and cells were rinsed with 12 mL artificial cerebral spinal fluid (aCSF) 
to wash away any residual media (0.5 mL/well). The lactate treatment stock 
solution was was diluted with DMEM to the correct concentration. The lactate 
treatment was heated to 37.9 °C, added to the 24 well plate (0.5 mL/well), and 
then placed back into the 37.5 °C humidified CO2 (5%) incubator for 4 h. This 
treatment protocol was followed for all treatments in this research, with treatment 
times specified (1 h or 4 h). 
2.3.4 Flow Cytometry 
 
Prior to flow cytometry preparations, PC12 cells were observed for healthy 
neurite outgrowth/cell viability. The previous treatment media was aspirated from 
the wells and cells were rinsed with 12 mL artificial cerebral spinal fluid (aCSF) to 
wash away residual media (0.5 mL/well). Cells were then treated with 12 mL (0.5 
mL/well) trypsin EDTA warmed to 37.9 °C, and gently shaken for several minutes 
until cells were loosened from the bottom of the wells. To neutralize the trypsin, 
12 mL (0.5 mL/well) of DMEM (with 10% HS and 1% antibiotics) was added to 
the wells and gently swirled to ensure proper mixing of the trypsin and DMEM. 
This mixture from each well was transferred to individual 1.5 mL centrifuge tubes 
(ThermoFisher) and centrifuged for 2 m at 1000 rotations per minute (RPM’s). 
The supernatant was aspirated from each tube and cells were re-suspended in 
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12 mL (0.5 mL/well) of live cell imaging solution (LCIS, ThermoFisher). One drop 
of propidium iodide (PI) ReadyProbes (ThermoFisher) was added to each tube of 
cells/LCIS, and the tubes were then vortexed to break up the cell pellet at the 
bottom of the tube. The tubes were covered with aluminum foil to protect against 
light damage and were incubated at room temperature for 20 m before starting 
data collection on the flow cytometer (BD Accuri C6; BD Bioscience). Flow 
cytometry was conducted in triplicates for each experiment with 10,000 cells per 
run. The PI staining was measured in percentages based off control groups and 
analysis parameters were kept consistent among treatment and control groups. 
 To measure cytosolic reactive oxygen species (ROS), CellROX Orange 
(ThermoFisher) probe was used instead of PI. The same cell preparation 
procedures were used as above, with the CellROX Orange prepped with LCIS in 
accordance with the protocol provided by ThermoFisher. The LCIS/CellROX 
cocktail was added into each 1.5 mL centrifuge tube (0.5 mL/tube), tubes were 
covered with aluminum foil to protect against light damage, and cells were 
allowed to incubate at room temperature for 30 m. After 30 m, the tubes were 
centrifuged at 1000 RPM’s for 2m. Supernatant was aspirated, 12 mL fresh LCIS 
(37.9 °C) was added to the centrifuge tubes (0.5 mL/tube), and the tubes were 
vortexed before data collection was carried out on the flow cytometer. 
2.3.5 Real-Time Imaging 
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Following 4 h treatment with DMEM (control) or L-lactate (4 mM) in 
DMEM, NGF-derived PC12 cells were prepared for real-time imaging with probes 
to measure for: calcium (Fluo-4AM, ThermoFisher), apoptosis (propidium iodide, 
ReadyProbe, ThermoFisher), ROS (CellROX Orange, ThermoFisher), and pH 
(pHrodo red AM, ThermoFisher).  
 For the calcium imaging, previous treatment media was aspirated from 
each well, rinsed with aCSF (0.5 mL/well), and aspirated again. Fluo-4AM dye 
was added to aCSF to a final concentration of 3 μM and was applied to the cells 
(0.5 mL/well). Cells were incubated at 37.9 °C for 30 m and then the media was 
aspirated from the wells. LCIS was added (1 mL/well) and viewed under an 
inverted microscope (Leica) with the appropriate fluorescent filters, a digital 
camera, mercury burner, and connection to a computer equipped with image 
capture software (Leica). After images were captured for each well, the 
backgrounds of the images were normalized and fluorescence was quantified 
using ImageJ software prior to background normalization. The analysis was 
completed using 6 randomly selected cells per treatment group and differences 
in intensity were compared among groups. 
 For the apoptosis imaging, treatment media was aspirated and each well 
was rinsed with aCSF (0.5 mL/well) to remove residual media. The aCSF was 
aspirated, cells were re-suspended in LCIS (0.5 mL/well), and 1 drop of PI 
ReadyProbe dye and 1 drop of NucBlue ReadyProbe (ThermoFisher) dye was 
added to each well according to the manufacture’s instructions . The cells were 
covered in foil and incubated at room temperature for 30 m before imaging. 
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 The oxidative stress detection probe, CellROX Orange, was prepared 
according to ThermoFisher’s protocol to final concentration of 5 μM. Previous 
treatment media was aspirated from each well, cells were re-suspended in the 
CellROX reagent, and incubated at 37.9 °C for 30 m. This media was removed 
and 0.5 mL of fresh LCIS with 1 drop of NucBlue was added to each well, 
incubated at room temperature (protected from light) for 20 m before imaging. 
 To measure intracellular pH, pHrodo red-AM was prepared in LCIS 
according to manufacturer’s protocol. Previous treatment media was aspirated 
and each well was rinsed once with LCIS (0.5 mL/well). The LCIS was aspirated, 
cells were re-suspended in the prepared pHrodo red-AM staining solution (0.5 
mL/well), and incubated at room temperature (protected from light) for 30 m. The 
staining solution was removed and cells were re-suspended in fresh LCIS (0.5 
mL/well) before imaging. 
2.3.6 Neuronal mRNA Expression Levels 
 
Whole brain primary neuronal cell cultures were treated with DMEM (control) 
or L-lactate (4mM) in DMEM for 1 h or 4 h prior to extraction. An RNA extraction 
kit (Qiagen) was used in accordance with the manufacturer’s instructions to 
extract the mRNA. The mRNA was converted to cDNA by the use of SuperScript 
VILO (ThermoFisher), with concentrations normalized to 250 ng/μL. Real time 
PCR (StepOnePLus real-time PCR system, Applied Biosystems) was conducted 
to measure mRNA levels of GAPDH (control), c-Fos, EGR1, GRP78, CHOP, and 
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VMAT2 using the respective primers (Applied Biosystems). Experiments were 
performed in quadruplicates and data was analyzed via Data Assist V. 3.01 
(Applied Biosystems) for changes in mRNA expression levels using GAPDH as 
the selected control. 
2.3.7 Statistical Analysis 
 
Data values were reported as mean ± SE.  Group means were compared 
using either unpaired Student’s t-test, or a one-way ANOVA (depending upon the 
experiment).  Significant difference between means was considered at p < 0.05.  
Bonferroni post hoc tests were used for multiple pair-wise comparisons among 
differences.  Statistical analyses were performed using GraphPad Prism, version 
5.0. 
2.3.8 Chemicals 
 
All chemicals/cell culture reagents and supplies were obtained from 
ThermoFisher, USA, with the exception of nerve growth factor (NGF, Sigma 
Aldrich) and L-lactate (Sigma Aldrich). 
2.4 Results 
2.4.1 L-lactate Increases Cytosolic Calcium in Primary Neuronal Cultures 
 
Primary neuronal cultures were incubated with DMEM (control) (Figure 2-
2A) or L-lactate (4 mM) in DMEM (Figure 2-2B) for 4 h, co-stained with Fluo-4AM 
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(ThermoFisher), a Ca2+ binding fluorescent dye, and NucBlue, and imaged in 
real-time under an inverted microscope.  
Fluorescence intensity was quantified using ImageJ software. Treatment 
of cells with L-lactate (4 mM) significantly (p < 0.05) increased the amount of 
cytosolic calcium in both neurons and PC12 cells (Figure 2-2C), compared to 
control. 
 
Figure 2-2. L-lactate Increases Cytosolic Calcium in Neurons.  
(A) Control cells were treated with DMEM for 4 h before being co-stained with 
Fluo-4AM and NucBlue. Real-time images were taken at 40x and 200x 
magnification. (B) Cells were treated for 4 h with L-lactate (4 mM) before being 
prepped for imaging. Real-time images were taken at 40x and 200x 
magnification. (C) The fluorescence intensity of the neurons treated with L-lactate 
(4 mM) or DMEM (control) and stained with Fluo-4AM, a cytosolic calcium stain, 
was quantified. The lactate treatment significantly (p < 0.05) increased the 
amount of cytosolic calcium compared to control. 
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2.4.2 L-lactate Increases Cytosolic ROS in Primary Neuronal Cultures and 
Dopaminergic-Like PC12 Cells 
 
Primary neuronal cell cultures were treated with either control DMEM 
(Figure 2-3A) or 4 mM L-lactate (Figure 2-3B), co-stained with cellROX orange 
and NucBlue (ThermoFisher), and analyzed in real time under an inverted 
microscope with appropriate fluorescent burner. Fluorescence intensity was 
quantified using ImageJ software. Treatment of cells with 4 mM L-lactate (n = 6) 
significantly increased the amount of cytosolic reactive oxygen species (ROS) 
compared to control (n = 6) (Figure 2-3C).   
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Figure 2-3. L-lactate Increases Cytosolic ROS in Neurons.  
(A) Control cells were treated with DMEM for 4 h before being co-stained with 
CellROX orange and NucBlue. Real-time images were taken at 40x and 200x 
magnification. (B) Cells were treated for 4 h with L-lactate (4 mM) before being 
prepped for imaging. Real-time images were taken at 40x and 200x 
magnification. (C) The fluorescence intensity of the neurons treated with L-lactate 
(4 mM) or DMEM (control) and stained with CellROX orange, a cytosolic ROS 
stain, was quantified. The lactate treatment significantly (p < 0.05) increased the 
amount of cytosolic ROS compared to control. 
 
NGF-derived PC12 cell cultures were treated with either control DMEM 
(Figure 2-4A) or 4 mM L-lactate (Figure 2-4B), co-stained with cellROX orange 
and NucBlue (ThermoFisher), and analyzed in real time under an inverted 
microscope with appropriate fluorescent burner. Fluorescence intensity was 
quantified using ImageJ software. Treatment of cells with 4 mM L-lactate (n = 6) 
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significantly increased the amount of cytosolic reactive oxygen species (ROS) 
compared to control (n = 6) (Figure 2-4C).   
 
Figure 2-4. L-lactate Increases Cytosolic ROS in PC12 Cells.  
(A) Control cells were treated with DMEM for 4 h before being co-stained with 
CellROX orange and NucBlue. Real-time images were taken at 200x 
magnification. (B) Cells were treated for 4 h with L-lactate (4 mM) before being 
prepped for imaging. Real-time images were taken at 200x magnification. (C) 
The fluorescence intensity of the PC12 cells treated with L-lactate (4 mM) or 
DMEM (control) and stained with CellROX orange, a cytosolic ROS stain, was 
quantified. The lactate treatment significantly (p < 0.05) increased the amount of 
cytosolic ROS compared to control. 
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2.4.3 L-lactate Increases Intracellular Acidification in Primary Neuronal 
Cultures and Dopaminergic-Like PC12 Cells 
 
Primary neuronal cultures (Figure 2-5A) and NGF derived PC12 cells 
(Figure 2-5C) were treated with either control DMEM or L-lactate (4 mM) for 4 hrs 
and then stained with pHrodo-red (ThermoFisher), a pH indicator that increases 
in fluorescence as pH becomes more acidic, and analyzed in real time. Images 
were captured for both treatment groups at 200x magnification and for PC12 
cells at 40x magnification. 
Fluorescence intensity was quantified using ImageJ software. Treatment 
of cells with 4 mM L-lactate significantly (p < 0.01) increased the amount of 
intracellular acidification compared to control, in both neuronal cultures (Figure 2-
5B) and PC12 cells (Figure 2-5D). 
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Figure 2-5. Real Time pH Imaging.  
(A) Neurons were treated with DMEM as a control or L-lactate (4 mM) and 
stained with pHrodo red. Images were taken at 40x. (B) L-lactate significantly (p 
< 0.01) increased the amount of cytosolic acidification in neuronal culture treated 
for 4 h. (C) PC12 cells were treated with DMEM or L-lactate (4 mM) for 4 h 
before being stained with pHrodo red. Images were taken at 40x and 200x 
magnification. (D) L-lactate significantly (p < 0.01) increased the amount of 
cytosolic acidification in PC12 cells treated for 4 h. 
2.4.4 L-lactate Alters Expression of Synaptic Plasticity Genes c-Fos and 
EGR1 in Primary Neuronal Cultures 
 
Primary neuronal cultures incubated with L-lactate (4 mM) had 
significantly (p < 0.0001) increased mRNA expression levels of the immediate 
early gene (IEG), c-Fos (Figure 2-6A), at 1 h versus control (5.77 ± 0.38 vs 1.01 
± 0.06 fold). The mRNA expression level of c-Fos at 4 h decreased significantly 
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(p < 0.0001) versus 1 h (0.10 ± 0.03 vs 5.77 ± 0.38) and control (0.10 ± 0.03 vs 
1.01 ± 0.06 fold). 
Neurons treated with L-lactate (4 mM) induced a significant (p < 0.05) 
increase in mRNA expression of the immediate early gene (IEG) and 
transcription factor, early growth response 1 (EGR1) at 1 h compared to control 
(2.16 ± 0.17 vs 1.01 ± 0.06 fold). No difference was found at 4 h, as levels 
returned towards baseline. (Figure 2-6B).  
2.4.5 L-lactate Induces Unfolded Protein Response in Primary Neuronal 
Cultures 
 
Primary neuronal cultures treated with L-lactate (4 mM) elicited a 
significant (p < 0.0001) decrease in the mRNA expression levels of CHOP (also 
known as DDIT3), a protein activated during ER stress, at 4 h versus control 
(0.06 ± 0.00 vs 1.01 ± 0.06), with no change in mRNA levels found at 1 h (Figure 
2-6C). 
A significant (p < 0.05) increase in mRNA expression levels of GRP78 
(also called HSPA5 or BiP) an ER chaperone, was induced in neurons at 4 h 
following L-lactate (4 mM) treatment versus control (1.40 ± 0.09 vs 1.01 ± 0.06, 
although no significance was found at 1 h (Figure 2-6D).  
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2.4.6 L-lactate Increases VMAT2 mRNA Expression in Primary Neuronal 
Cultures 
 
Primary neuronal cultures treated with L-lactate (4 mM) elicited a 
significant (p < 0.0001) increase in the mRNA expression levels of VMAT2, a 
protein involved in maintenance of neuronal vesicles, at 1 h versus control (0.06 
± 0.00 vs 1.01 ± 0.06), with no change in mRNA levels found at 4 h (Figure 2-
6E). 
 
Figure 2-6. Effect of L-lactate on mRNA Expression Levels in Primary Neuronal 
Cultures.  
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(A) L-lactate (4 mM) significantly (p < 0.0001) increased the mRNA expression 
level of c-Fos at 1 h compared to control, and significantly decreased the mRNA 
levels of c-Fos at 4 h compared to 1 h (*** vs control, ### vs 1 h). (B) L-lactate (4 
mM) significantly (p < 0.0001) increased the mRNA expression level of EGR1 at 
1 h compared to control, although no difference was observed at 4 h (*** vs 
control). (C) L-lactate (4 mM) significantly (p < 0.0001) decreased the mRNA 
expression level of CHOP at 4 h compared to control (### vs control). No 
difference was observed at 1 h. (D) L-lactate significantly (p < 0.01) increased the 
mRNA expression level of GRP78 at 4 h compared to control (* vs control). (E) L-
Lactate significantly (p < 0.0001) increased mRNA expression level of VMAT2 at 
1 h compared to control (*** vs control). 
 
2.4.7 L-lactate Increases Cell Death in Primary Neuronal Cultures and 
NGF-Derived PC12 Cells 
 
Neuronal cultures were treated with either control DMEM or 4 mM L-
lactate in DMEM, loaded with PI and NucBlue ready probes (ThermoFisher), and 
analyzed in real time. The 4 mM L-lactate treatment stimulated an increase in 
cells staining positive for PI compared to control (Figure 1E). There was no 
significant (p < 0.05) difference between the amount of neurons staining positive 
for NucBlu between control and the treatment group. Images were captured for 
controls at 40x magnification and 200x magnification (Figure 1A) and 4 mM L-
lactate at 40 and 200x magnification (Figure 1B).  
Neuronal cultures treated with either control DMEM (n=5) or 4 mM L-
lactate (n=6) were stained with PI and analyzed via flow cytometry. The amount 
of cells staining positive for PI increased in the 4 mM L-lactate treatment group 
(31.6%) compared to the control group (21.4%) (Figure 1D). 
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Figure 2-7. L-lactate Increases Cell Death in Primary Neuronal Cultures.  
(A) Cells were treated with DMEM as a control, co-stained with PI and NucBlue, 
and imaged using an inverted microscope (40x and 200x magnification). (B) 
Cells were treated with 4 mM L-lactate for 4 h, co-stained with PI and NucBlue, 
and imaged using an inverted microscope (40x and 200x magnification). (C) L-
lactate (4 mM) had a trend to increase PI stained cells compared to control, 
although no statistical difference was found. (D) L-Lactate PI Flow Cytometry. 
Cells treated with control DMEM for 4 h experienced 21.4% of the population 
staining positive for PI. Cells treated with 4 mM L-lactate for 4 h experienced 
31.6% of the population staining positive for PI. (E) PI Fluorescence 
Quantification. The ratio and percentage of neurons that fluoresced positively for 
PI staining when treated for 4 h with either control or 4 mM L-lactate. 
 
NGF-derived PC12 cells treated with either DMEM as a control (Figure 2-
8B) or increasing concentrations of L-lactate [1.5 mM (Figure 2-8C), 2 mM 
(Figure 2-8D), 3 mM (Figure 2-8F), 4 mM (Figure 2-8G), 8 mM (Figure 2-8H)] 
increased in percentage of cells staining positive for propidium iodide (PI) in a 
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dose dependent manner (14.2, 18.5, 20.8, 27.2, 36.8, 53.4, respectively), 
analyzed via flow cytometry.  
A dose curve was plotted for the increasing concentrations of L-lactate, 
and the EC50 was calculated to be 3.28 mM (Figure 2-8A). The experiment was 
repeated at the L-lactate concentration of 4 mM and there was a significant (p > 
0.05) increase in percentage of cells staining positive for PI compared to control 
(Figure 2-8E). 
PC12 cells were treated with either control DMEM (Figure 2-8I) or 4 mM L-
lactate in DMEM (Figure 2-8J, 2-8K), pre-loaded with PI and NucBlue ready 
probes (ThermoFisher), and their fluorescence was quantified. Cells treated with 
4 mM L-lactate significantly (p < 0.05) increased in percentage stained positive 
for PI compared to control, however there was no significant difference in 
percentage stained positive for NucBlue between the two groups. 
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Figure 2-8. L-lactate Increases Cell Death in PC12 Cells.  
(A) L-lactate induced a dose-dependent increase in cells staining positive for PI, 
with an EC50 value of about 3.3 mM. Cells were treated with (B) control DMEM, 
(C) 1.5 mM L-lactate, (D) 2 mM L-lactate, (F) 3 mM L-lactate, (G) 4 mM L-lactate, 
or (H) 8 mM L-lactate for 4 hours before being stained with PI and analyzed via 
flow cytometry. The percentage of cells stained positive for PI is the value to the 
right of the red line. (E) 4 mM L-lactate significantly (p < 0.05) increased the 
percentage of cells stained positive for PI compared to control. (I) Cells were 
treated with DMEM as a control, co-stained with PI and NucBlue, and imaged 
using an inverted microscope (40x magnification). (J) Cells were treated with 4 
mM L-lactate for 4 h, co-stained with PI and NucBlue, and imaged using an 
inverted microscope (40x magnification) and (K) 200x magnification. 
2.5 Discussion 
The present study evaluated the role L-lactate contributes towards toxicity 
and neuronal degeneration in both primary neuronal cultures and dopaminergic-
like NGF-derived PC12 cells. While a majority of literature on lactate/lactic acid 
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from the 20th century concluded this substrate as being a dead-end metabolic 
product present in exercising muscles, current research is growing towards more 
important implications in CNS function and dysfunction. As such, we report 
molecular mechanisms by which L-lactate can induce degenerative cascades in 
primary neuronal cultures and dopaminergic-like PC12 cells. 
The cytotoxic role of calcium ions to neurons has been well established in 
the literature. Calcium build-up occurs intracellularly as a result of impaired 
transporters, mitochondrial dysfunction, ER dysfunction, or a combination of 
these factors. Increased levels of intracellular calcium can lead to excessive 
neuronal depolarization, leading to “excitotoxicity” and subsequent cell death. 
Due to the similarity in chemical structure between glutamate, the primary 
excitatory neurotransmitter, and lactate, we hypothesized that elevated lactate 
concentrations would elicit increases in intracellular calcium. To evaluate the 
effects of L-lactate on intracellular calcium levels, we treated primary neuronal 
cultures with 4 mM L-lactate for 4 h and stained the cells with Fluo-4AM, a 
fluorescent cytosolic calcium dye. Real-time imaging quantification revealed that 
L-lactate significantly increased the percentage of cells staining positive for Fluo-
4AM. It is likely that a combination of events contribute to the sustained increase 
of calcium, such as activation of Ca2+-dependent receptors such as NMDA-R, or 
Ca2+ leak from organelles such as the mitochondria during oxidative stress, or 
the endoplasmic reticulum during ER-stress. 
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Oxidative stress is a cellular condition that occurs when the generation of 
reactive oxygen species (ROS) surpasses the ability of the body to neutralize 
and effectively eliminate the ROS. It was not surprising for us to see increases in 
cytosolic ROS following L-lactate (4 mM) treatment, as this has been established 
in the literature from mitochondrial generated ATP. Mitochondrial dysfunction can 
lead to reduced energy/ATP generation (11), impaired free radical scavenging 
capabilities (52) and dysfunctional monocarboxylate transporters (29, 34, 70). It 
is through these impaired cellular processes that ROS accumulates in cell bodies 
such as neurons, eventually triggering an apoptotic-cascade ending in neuronal 
death. 
A crucial component of cellular homeostasis is intracellular pH levels, and 
this is often disturbed in neurodegenerative models (AD, PD) as well as ischemia 
(42). Modest decreases in pH have been shown to provide protective defenses 
for cells, however severe acidosis (intracellular pH less than 6.4) increases 
cellular damage observed in the pathologies listed above. It has been 
demonstrated that oxidative stress can disrupt oxidative phosphorylation, leading 
to increased production of lactate, with ensuing acidosis (42). As such, in this 
study we were able to demonstrate that L-lactate, at elevated concentrations 
commonly found in neurodegenerative disease models (4 mM), induces cytosolic 
acidification, perhaps as a response to increased intracellular calcium, increased 
ROS, or a combination. 
Research has been conducted in primary culture mouse neurons and in 
vivo showing that L-lactate can function as a signaling molecule that stimulates 
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plasiticity-related gene expression in neurons (71). L-lactate functions as a 
mediator for long-term plasticity and memory through the induction of expression 
of immediate early genes (IEGs), such as early growth response 1 (EGR1) and 
c-Fos. The expression of EGR1 is widely regulated by multiple environmental 
factors and is implicated heavily in synaptic plasticity and information encoding 
processes, suggesting a role for EGR1 in perceving the environment and forming 
an appropriate response to stimuli. Furthermore, EGR1 has been associated in 
the literature with neuropsychiatric illnesses where synaptic plasticity and activity 
is dysregulated, such as stress-related mood disorders, schizophrenia, and 
addiction models (21). Also, increased levels of EGR1 have been found in AD 
brains, with implications in regulating tau phosphorylation leading to 
acummulated proteins as is found in AD pathology (41). Interestingly, it has been 
reported that while acute stressors elicit an increase in mRNA expression levels 
of EGR1 and c-Fos in brain areas such as the neocortex, hippocampus, nucleus 
accumbens, and the paraventricular nucleus (PVN) located in the hypothalamus, 
chronic exposure to the same stressor produces a blunted IEG expression 
response (18, 46, 55, 67). Consistent with current literature, in this study we 
demonstrated that L-lactate (4 mM) induces increased mRNA expression of the 
IEGs c-Fos and EGR1 at 1 h, with expression levels returning back towards 
baseline at 4 h. This finding suggests a key role in L-lactate’s ability to impact 
synaptic learning processes, which are often dysregulated in neurodegenerative 
models. 
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Protein structure and function is largely regulated by chaperone molecules 
and lactic acidosis can contribute to conformational changes to tertiary protein 
structure, leading to the misfolding of protein, thus reducing their activity and 
further exacerbating the acidosis.  This protein misfolding is largely implicated in 
the pathological development of AD (6). A 2005 study reported increased protein 
levels of GRP78, a molecular chaperone during the unfolded protein response 
(UPR), in AD temporal cortex and hippocampus via Western blot (35). In 
concurrence, in this study we demonstrated that L-lactate (4 mM) signficantly 
increases mRNA expression levels of GRP78 at 4 h, suggesting a role of L-
lactate in eliciting the UPR. It has been shown in the literature that chronic UPR 
can result in increased expression of CHOP (DDIT3), a pro-apoptotic 
transcription factor implicated in the ER stress response. In the current study we 
showed that L-lactate (4 mM) induced a signficant decrease in mRNA expression 
levels of CHOP at 4h but not 1h, suggesting that the neurons were experiencing 
uncontrollable protein misfolding and subsequent death. 
A hallmark of neuronal homeostasis and regulation lies through vesicular 
transport. Vesicular monoamine transporter 2 (VMAT2) is expressed primarily in 
the CNS, with roles in organizing and releasing neurotransmitters. Dysregulation 
of VMAT2 through exogenous stimulant exposure has been implicated in 
neurotoxicity and addiction (24). Dyfunction of VMAT2 has also been implicated 
in PD pathologies (40). Furthermore, a 2005 study showed VMAT2 knock-out 
mice were unable to store/release dopamine in their synapses, indicating the 
importance of VMAT2 in proper neurotransmission (17). Consistent with current 
44 
literature, in this study we demonstrated that VMAT2 mRNA expression is 
increased at 1 h, with levels returning back towards baseline at 4 h. This 
suggests that acute exposure to a stimulant such as L-lactate can induce 
increased vesicular transport in neuronal synapses through acidification and/or 
calcium levels, however chronic exposure can diminish the ability of VMAT2 to 
successfully release and take-up neurotransmitters in the synapse, leading to 
further cellular dysregulation. 
Using flow cytometry, we confirmed that NGF-derived PC12 cells 
incubated with L-lactate for 4 h increased positive PI staining in a dose 
dependent manner (Figure 1). A dose-response curve revealed an EC50 value for 
L-lactate of 3.28 mM (Figure 1A). Blood lactate concentrations are usually 1-2 
mM at rest, however with excess accumulation as experienced during intense 
exercise, these levels can exceed 20 mM (12). Rises in CSF lactate have been 
well established in neurodegenerative disease models (2, 3, 44, 49, 62, 71, 72). 
It is also reported that blood or CSF lactate increases (>2.1 mM) (32) can be an 
indicator of mitochondrial disease. Our EC50 value for L-lactate-induced 
increases in cell death (represented by increased percentage of cells staining 
positive for PI) corresponds with the apparent increases in brain L-lactate 
concentrations in neurodegenerative models reported thoroughly in the literature. 
In support of the quantitative cell death observed via flow cytometry, we also 
observed significant increases in fluoresced PC12 cells following L-lactate (4 
mM) treatment via real-time imaging versus control. The flow cytometry and real-
time imaging experiments were re-conducted using primary neuronal cultures 
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with similar trends observed, further supporting the role of lactate in modulating 
CNS activity. There is a growing basis of research indicating that accumulation of 
lactate in the central nervous system, through impairment of MCTs (29, 34, 70), 
altered activity of lactate dehydrogenase (LDH), and/or hypoxic/ischemic 
conditions (63), can lead to metabolic acidosis, increased ROS, and increased 
levels of intracellular calcium; all precursors to cell death individually and in 
combination. This current study provides further evidence for the role of lactate in 
neurodegeneration in the CNS, and allows for continued studies into precise 
cellular mechanistic pathways.  
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 Summary, Limitations, and Future Directions 
3.1 Summary 
Dysregulation of homeostatic mechanisms in the CNS remain a 
cornerstone of neurodegenerative diseases, ischemia reperfusion injuries, and 
physiological aging. While neurodegenerative disorder studies focus largely on 
the clinical presentation of these diseases such as protein aggregation, little 
research has been done to explore the effects of potential biochemical markers 
that facilitate the homeostatic dysregulation. As such, we explored the effects of 
lactate on neuronal function. 
In the current study we explored whether lactate could induce cytotoxic 
mechanisms that are heavily implicated in neuronal degeneration. We 
demonstrated that L-lactate activates a cellular cascade that results in increased 
cytosolic calcium, increased cytosolic ROS and increased intracellular pH. 
Furthermore, lactate induced increases in mRNA expression levels of EGR1 and 
c-Fos, proteins that are upregulated during synaptic plasticity processes. Lactate 
also induced increases in mRNA expression levels of GRP78 and CHOP, 
proteins upregulated during ER stress and UPR. In support of the cytotoxic 
mechanisms explored above, L-lactate also induced significant increases in cell 
death experienced in both primary neuronal cultures and dopaminergic-like PC12 
cells. Taken together, this suggests that lactate-induced cell death is a result or 
contribution of several cellular pathways explored in this study, and can provide 
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further insight to the development and maintenance of neurodegenerative 
diseases. 
3.2 Limitations 
 It is important to note several limitations of the present study. First, all 
experiments were conducted on primary neuronal cultures, not isolated from 
specific areas of the brain. This could have implications for the data sets, as 
various brain areas are correlated with various levels of expression of substrates 
and receptors. In addition, the flow cytometry machine that was used to carry out 
the PI flow cytometry data collection does not contain a UV laser line, a 
necessary component for the use of the NucBlue stain. NucBlue permeates all 
cell membranes (intact and compromised), which can provide a clearer 
understanding of the effects of L-lactate on the whole neuronal population. To 
improvise this equipment shortcoming, we used PI stain alone, which stains 
compromised membranes but cannot permeate and stain cells with an intact 
membrane, still allowing us to quantify the cell death experienced upon L-lactate 
treatment. 
 Our current study with lactate only utilized cell culture. As is common in 
research practice, studies progress from cell culture, to animal models and 
eventually make it to human trials. A limitation for this study is that we lack 
animal model support. As such, future studies will include animal models and the 
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contributions of lactic acid/lactate to the development of neurodegenerative 
disease.  
3.3 Future Directions 
Since we have identified lactate to contribute to increases in intracellular 
calcium concentrations, we would like to continue our research into more precise 
signaling pathways. Specifically, we plan on exploring the effects of lactate on 
NMDA-R pathways, as it has been demonstrated in the literature that oligomeric 
forms of β-amyloid, as well as lactate, have been shown to interact with NMDA-
R, leading to increases in levels of intracellular calcium, mitochondrial calcium 
excess, oxidative stress, and apoptosis (19). 
We would also like to expand our research to routes further exploring the 
role of lactate in the UPR and subsequent protein aggregation that is common 
among neurodegenerative disorders such as AD, PD, and dementia with lewy 
bodies. 
It would be beneficial for the study to include acute versus chronic exposure 
to lactate, as it is pertinent to further understanding lactate’s role in 
neurodegenerative diseases, which progress chronically over time. This could be 
achieved through acute administration of lactate through tail vein infusion, and 
the chronic intracerebrovascular (ICV) infusion of lactate over four weeks to look 
for neurodegenerative markers for degeneration. 
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A Raw Data and Statistics 
 
Table A-1. Two-tailed T-test for mRNA Expression of GRP78 (HSPA5) 
Table Analyzed HSPA5 Neurons 3_13_18 
Column A control 
vs vs 
Column C 4 mm Lactate 4 hr 
    
Unpaired t test   
P value 0.0145 
P value summary * 
Are means signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=3.398 df=6 
    
How big is the difference?   
Mean ± SEM of column A 1.006 ± 0.06478 N=4 
Mean ± SEM of column C 1.395 ± 0.09447 N=4 
Difference between means -0.3893 ± 0.1146 
95% confidence interval -0.6696 to -0.1090 
R square 0.6581 
    
F test to compare variances   
F,DFn, Dfd 2.127, 3, 3 
P value 0.5513 
56 
P value summary ns 
Are variances significantly different? No 
 
Table A-2. Two-tailed T-test for mRNA Expression of EGR1 
Table Analyzed EGR1 Neurons 3_13_18 
Column A control 
vs vs 
Column B 4 mM Lactate 1 hr 
    
Unpaired t test   
P value 0.0007 
P value summary *** 
Are means signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=6.410 df=6 
    
How big is the difference?   
Mean ± SEM of column A 1.006 ± 0.06478 N=4 
Mean ± SEM of column B 2.157 ± 0.1675 N=4 
Difference between means -1.151 ± 0.1796 
95% confidence interval -1.591 to -0.7118 
R square 0.8726 
    
F test to compare variances   
F,DFn, Dfd 6.684, 3, 3 
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P value 0.1530 
P value summary ns 
Are variances significantly different? No 
 
Table A-3. Two-tailed T-test for mRNA Expression of c-FOS (Control vs 1 h) 
Table Analyzed c-fos Neurons 3_13_18 
Column A control 
vs vs 
Column B 4 mM Lactate 1 hr 
.    
Unpaired t test   
P value < 0.0001 
P value summary **** 
Are means signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=12.52 df=6 
    
How big is the difference?   
Mean ± SEM of column A 1.006 ± 0.06478 N=4 
Mean ± SEM of column B 5.773 ± 0.3751 N=4 
Difference between means -4.767 ± 0.3807 
95% confidence interval -5.699 to -3.836 
R square 0.9632 
    
F test to compare variances   
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F,DFn, Dfd 33.53, 3, 3 
P value 0.0166 
P value summary * 
Are variances significantly different? Yes 
 
Table A-4. Two-tailed T-test for mRNA Expression of c-FOS (Control vs 4 h) 
Table Analyzed c-fos Neurons 3_13_18 
Column A control 
vs vs 
Column C 4 mm Lactate 4 hr 
    
Unpaired t test   
P value < 0.0001 
P value summary **** 
Are means signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=12.52 df=6 
    
How big is the difference?   
Mean ± SEM of column A 1.006 ± 0.06478 N=4 
Mean ± SEM of column C 0.1003 ± 0.03217 N=4 
Difference between means 0.9058 ± 0.07233 
95% confidence interval 0.7288 to 1.083 
R square 0.9631 
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F test to compare variances   
F,DFn, Dfd 4.054, 3, 3 
P value 0.2804 
P value summary ns 
Are variances significantly different? No 
 
Table A-5. Two-tailed T-test for mRNA Expression of c-FOS (1 h vs 4 h) 
Table Analyzed c-fos Neurons 3_13_18 
Column B 4 mM Lactate 1 hr 
vs vs 
Column C 4 mm Lactate 4 hr 
    
Unpaired t test   
P value < 0.0001 
P value summary **** 
Are means signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=15.07 df=6 
    
How big is the difference?   
Mean ± SEM of column B 5.773 ± 0.3751 N=4 
Mean ± SEM of column C 0.1003 ± 0.03217 N=4 
Difference between means 5.673 ± 0.3765 
95% confidence interval 4.752 to 6.594 
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R square 0.9743 
    
F test to compare variances   
F,DFn, Dfd 135.9, 3, 3 
P value 0.0021 
P value summary ** 
Are variances significantly different? Yes 
 
Table A-6. Two-tailed T-test for mRNA Expression of CHOP (DDIT3) (Control vs 
1 h) 
Table Analyzed Ddit3 Neurons 3_13_18 
Column A control 
vs vs 
Column B 4 mM Lactate 1 hr 
    
Unpaired t test   
P value 0.6199 
P value summary ns 
Are means signif. different? (P < 0.05) No 
One- or two-tailed P value? Two-tailed 
t, df t=0.5228 df=6 
    
How big is the difference?   
Mean ± SEM of column A 1.006 ± 0.06478 N=4 
Mean ± SEM of column B 0.9180 ± 0.1555 N=4 
61 
Difference between means 0.08806 ± 0.1684 
95% confidence interval -0.3241 to 0.5002 
R square 0.04357 
    
F test to compare variances   
F,DFn, Dfd 5.760, 3, 3 
P value 0.1844 
P value summary ns 
Are variances significantly different? No 
 
Table A-7. Two-tailed T-test for mRNA Expression of CHOP (DDIT3) (Control vs 
4 h) 
Table Analyzed Ddit3 Neurons 3_13_18 
Column A control 
vs vs 
Column C 4 mm Lactate 4 hr 
    
Unpaired t test   
P value < 0.0001 
P value summary **** 
Are means signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=14.63 df=6 
    
How big is the difference?   
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Mean ± SEM of column A 1.006 ± 0.06478 N=4 
Mean ± SEM of column C 0.05552 ± 0.004758 N=4 
Difference between means 0.9506 ± 0.06496 
95% confidence interval 0.7916 to 1.110 
R square 0.9727 
    
F test to compare variances   
F,DFn, Dfd 185.4, 3, 3 
P value 0.0013 
P value summary ** 
Are variances significantly different? Yes 
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Table A-8. Two-tailed T-test for mRNA Expression of VMAT2 (Control vs 1 h) 
Table Analyzed vmat2 Neurons 3_13_18 
Column A control 
vs vs 
Column B 4 mM Lactate 1 hr 
    
Unpaired t test   
P value 0.0003 
P value summary *** 
Are means signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=7.251 df=6 
    
How big is the difference?   
Mean ± SEM of column A 1.006 ± 0.06478 N=4 
Mean ± SEM of column B 2.057 ± 0.1297 N=4 
Difference between means -1.051 ± 0.1450 
95% confidence interval -1.406 to -0.6963 
R square 0.8976 
    
F test to compare variances   
F,DFn, Dfd 4.007, 3, 3 
P value 0.2842 
P value summary ns 
Are variances significantly different? No 
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Table A-9. Two-tailed T-test for mRNA Expression of VMAT2 (Control vs 4 h) 
Table Analyzed vmat2 Neurons 3_13_18 
Column A control 
vs vs 
Column C 4 mm Lactate 4 hr 
    
Unpaired t test   
P value 0.0661 
P value summary ns 
Are means signif. different? (P < 0.05) No 
One- or two-tailed P value? Two-tailed 
t, df t=2.243 df=6 
    
How big is the difference?   
Mean ± SEM of column A 1.006 ± 0.06478 N=4 
Mean ± SEM of column C 1.301 ± 0.1142 N=4 
Difference between means -0.2945 ± 0.1313 
95% confidence interval -0.6158 to 0.02684 
R square 0.4560 
    
F test to compare variances   
F,DFn, Dfd 3.109, 3, 3 
P value 0.3765 
P value summary ns 
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Are variances significantly different? No 
 
Table A-10. Two-tailed T-test for PI Quantification in Neurons 
Table Analyzed PI Lactate 4 hr neurons 2_15_18 
Column A 0 
vs vs 
Column B 4 
    
Unpaired t test   
P value 0.0021 
P value summary ** 
Are means signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=4.255 df=9 
    
How big is the difference?   
Mean ± SEM of column A 18.86 ± 1.535 N=5 
Mean ± SEM of column B 31.83 ± 2.456 N=6 
Difference between means -12.97 ± 3.049 
95% confidence interval -19.87 to -6.077 
R square 0.6680 
    
F test to compare variances   
F,DFn, Dfd 3.074, 5, 4 
P value 0.2992 
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P value summary ns 
Are variances significantly different? No 
 
Table A-11. Two-tailed T-test for RT-ROS Quantification in Neurons 
Table Analyzed ROS lactate 
Column A 0 
vs vs 
Column B 4 
    
Unpaired t test   
P value 0.0214 
P value summary * 
Are means signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=2.725 df=10 
    
How big is the difference?   
Mean ± SEM of column A 1.755 ± 0.4230 N=6 
Mean ± SEM of column B 4.115 ± 0.7557 N=6 
Difference between means -2.360 ± 0.8660 
95% confidence interval -4.289 to -0.4302 
R square 0.4261 
    
F test to compare variances   
F,DFn, Dfd 3.192, 5, 5 
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P value 0.2285 
P value summary ns 
Are variances significantly different? No 
 
Table A-12. Two-tailed T-test for RT-pH Quantification in Neurons 
Table Analyzed pHi lactate 
Column A 0 
vs vs 
Column B 4 
    
Unpaired t test   
P value 0.0088 
P value summary ** 
Are means signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=3.246 df=10 
    
How big is the difference?   
Mean ± SEM of column A 0.3227 ± 0.04263 N=6 
Mean ± SEM of column B 0.5975 ± 0.07315 N=6 
Difference between means -0.2748 ± 0.08466 
95% confidence interval -0.4634 to -0.08614 
R square 0.5130 
    
F test to compare variances   
68 
F,DFn, Dfd 2.944, 5, 5 
P value 0.2610 
P value summary ns 
Are variances significantly different? No 
 
Table A-13. Two-tailed T-test for RT-Calcium Quantification in Neurons 
Table Analyzed Calcium Lactate 
Column A 0 
vs vs 
Column B 4 
    
Unpaired t test   
P value 0.0116 
P value summary * 
Are means signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=3.156 df=9 
    
How big is the difference?   
Mean ± SEM of column A 0.05953 ± 0.004102 N=5 
Mean ± SEM of column B 0.2159 ± 0.04470 N=6 
Difference between means -0.1564 ± 0.04956 
95% confidence interval -0.2685 to -0.04428 
R square 0.5252 
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F test to compare variances   
F,DFn, Dfd 142.5, 5, 4 
P value 0.0003 
P value summary *** 
Are variances significantly different? Yes 
 
Table A-14. Two-tailed T-test for RT-PI Quantification in Neurons 
Table Analyzed PI Lactate Column 
Column A 0 
vs vs 
Column B 4 
    
Unpaired t test   
P value 0.0116 
P value summary * 
Are means signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=3.585 df=6 
    
How big is the difference?   
Mean ± SEM of column A 14.95 ± 0.5188 N=4 
Mean ± SEM of column B 31.58 ± 4.608 N=4 
Difference between means -16.63 ± 4.637 
95% confidence interval -27.97 to -5.277 
R square 0.6817 
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F test to compare variances   
F,DFn, Dfd 78.89, 3, 3 
P value 0.0047 
P value summary ** 
Are variances significantly different? Yes 
 
Table A-15. Two-tailed T-test for RT-pH Quantification in PC12 Cells 
Table Analyzed pHi 
Column A Control 
vs vs 
Column B 4 mM L-Lac 
    
Unpaired t test   
P value 0.0080 
P value summary ** 
Are means signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=3.303 df=10 
    
How big is the difference?   
Mean ± SEM of column A 1.210 ± 0.3064 N=6 
Mean ± SEM of column B 2.341 ± 0.1530 N=6 
Difference between means -1.131 ± 0.3424 
95% confidence interval -1.894 to -0.3680 
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R square 0.5217 
    
F test to compare variances   
F,DFn, Dfd 4.012, 5, 5 
P value 0.1536 
P value summary ns 
Are variances significantly different? No 
 
Table A-16. Two-tailed T-test for RT-ROS Quantification in PC12 Cells 
Table Analyzed Cyto ROS 
Column A Control 
vs vs 
Column B 4 mM L-Lac 
    
Unpaired t test   
P value 0.0246 
P value summary * 
Are means signif. different? (P < 0.05) Yes 
One- or two-tailed P value? Two-tailed 
t, df t=2.644 df=10 
    
How big is the difference?   
Mean ± SEM of column A 3.285 ± 0.7930 N=6 
Mean ± SEM of column B 5.786 ± 0.5157 N=6 
Difference between means -2.501 ± 0.9459 
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95% confidence interval -4.609 to -0.3935 
R square 0.4114 
    
F test to compare variances   
F,DFn, Dfd 2.364, 5, 5 
P value 0.3668 
P value summary ns 
Are variances significantly different? No 
 
Table A-17. Non-linear fit for dose-dependent response of PC12 cells to L-lactate 
Boltzmann sigmoidal   
Best-fit values   
Bottom 12.33 
Top 43.83 
V50 3.282 
Slope 1.285 
Std. Error   
Bottom 7.845 
Top 4.669 
V50 0.7646 
Slope 0.9474 
95% Confidence Intervals   
Bottom -4.088 to 28.75 
Top 34.06 to 53.61 
V50 1.682 to 4.883 
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Slope -0.6979 to 3.268 
Goodness of Fit   
Degrees of Freedom 19 
R square 0.6958 
Absolute Sum of Squares 923.9 
Sy.x 6.973 
Number of points   
Analyzed 23 
 
